Affiliations: [a] Department of Laboratory Medicine, Medical University of Gdańsk, Gdańsk, Poland | [b] Paul Flechsig Institute for Brain Research, University of Leipzig, Leipzig, Germany | [c] Department of Molecular Medicine, Medical University of Gdańsk, Gdańsk, Poland
Correspondence:
[*]
Correspondence to: Andrzej Szutowicz, Department of Laboratory Medicine, Medical University of Gdańsk,
Dębinki 7 str., Bldg. 27, 80-211 Gdańsk, Poland. Tel.: +48 583 492 770; Fax: +48 583 492 784; aszut@gumed.edu.pl
Abstract: The pyruvate-derived acetyl-CoA is a principal direct precursor substrate for bulk energy synthesis in the brain. Deficits of pyruvate dehydrogenase in the neocortex are common features of Alzheimer’s disease and other age-related encephalopathies in humans. Therefore, amyloid-β overload in brains of diverse transgenic Alzheimer’s disease model animals was investigated as one of neurotoxic compounds responsible for pyruvate dehydrogenase inhibition yielding deficits of cholinergic neurotransmission and cognitive functions. Brains of aged, 14–16-month-old Tg2576 mice contained 0.6μmol/kg levels of amyloid-β1 - 42. Activities of pyruvate dehydrogenase complex, choline acetyltransferase, and several enzymes of acetyl-CoA and energy metabolism were found to be unchanged in both forebrain mitochondria and synaptosomes of Tg2576 mice, indicating preservation of structural integrity at least in cholinergic neuronal cells. However, in transgenic brain synaptosomes, pyruvate utilization, mitochondrial levels, and cytoplasmic acetyl-CoA levels, as well as acetylcholine content and its quantal release, were all found to be decreased by 25–40% . On the contrary, activation of pyruvate utilization was detected and no alterations in acetyl-CoA content and citrate or α-ketoglutarate accumulation were observed in transgenic whole brain mitochondria. These data indicate that amyloid-β evoked deficits in acetyl-CoA are confined to mitochondrial and cytoplasmic compartments of Tg2576 nerve terminals, becoming early primary signals paving the path for further stages of neurodegeneration. On the other hand, acetyl-CoA synthesis in mitochondrial compartments of glial cells seems to be activated despite amyloid-β accumulated in transgenic brains.
